Business & Regulation

Sitting Down With… Stanley Crooke, Chairman of the Board & Chief Executive Officer at Ionis Pharmaceuticals.

The pharma industry understands the importance of neglected diseases, but the field is still not receiving the attention it deserves.

Single-source chromatography resin leads to requirements for supply security.

What does the controversial genome editing work of Jiankui He mean for biomedical research?

Brexit: As UK politicians debate the merits of the Prime Minister’s Withdrawal Agreement, we debate its potential impact for pharma...

Oscars of science, drug shortage reporting requirements, and a new gene therapy... What’s new for pharma in business?

The business of making biopharmaceuticals is expensive – so the more data you have to back up decisions, the better.

Eva discovers that Gene's project management skills leave a lot to be desired...

A new gene therapy, a procurement process gone wrong, and backing away from a biosimilar…

The FDA’s Janet Woodcock explains how manufacturing will change in the coming years.